ข่าวประชาสัมพันธ์ GlaxoSmithKline+the project

Anantara Tented Camp Kafue River Receives Two Accolades at the LIV Hospitality Design Awards

Anantara Tented Camp Kafue River team is honoured to receive two awards at the sixth edition of the LIV Hospitality Design Awards, which recognises the most visionary hospitality architecture and design projects across the globe every year. The luxury camp takes the top distinction in both the Architecture (Living Space, Lodge) and Interior Design (Living Space, Africa) categories. Anantara Kafue was also chosen as a "Jury Pick", exclusively awarded to projects that achieved more than 80 points

Central Pattana Plc, Thailand's largest r... Central Pattana Announces $3 Billion Investment to Expand Mixed-Use Developments Across Thailand — Central Pattana Plc, Thailand's largest retail-led real...

Chulalongkorn University researchers have... From Fishing Nets to Filament: Chula Innovation Turns Marine Waste into 3D Printing Material — Chulalongkorn University researchers have developed a break...

Thai Cement Manufacturers Association (TC... TCMA Marks National Milestone, Driving Thailand's Cement Industry toward Net Zero 2050 — Thai Cement Manufacturers Association (TCMA) marked a significant...

GSK, a global biopharmaceutical company, ... Marija Krstic Appointed as General Manager for GSK Thailand — GSK, a global biopharmaceutical company, has officially named Marija Krstic as the new Gener...

Cipla ได้รับการอนุมัติขั้นสุดท้าย เพื่อวางจำหน่าย Sumatriptan Nasal Spray, 20 mg ยาสามัญที่มีต้นแบบจาก IMITREX(R) ของ GlaxoSmithKline

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (ในที่นี้เรียกว่า "Cipla") ประกาศในวันนี้ว่า บริษัทได้รับการอนุมัติขั้นสุดท้ายหลังจากที่ได้ยื่นขึ้นทะเบียนยาใหม่...

Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX(R) (Sumatriptan Nasal Spray, 20 mg)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for...

ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis

INSPIRING study results contribute to the extensive body of evidence for dolutegravir, the leading integrase strand transfer inhibitor, in diverse and hard to treat...

GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has...

Photo Release: GSK receives award for Good Corporate Governance 2014

Mr. Viriya Chongphaisal (Left), General Manager of GlaxoSmithKline Thailand (GSK), a leading pharmaceutical research and development company, receives the “Good Corporate Governance 2014” award from Mr.Panthep Klanarongran (Right)....

Photo Release: GSK Medicine Bank helps flood victims

Gen Pichate Wisaijorn (5th from left), Assistant Commander-in-Chief, Royal Thai Army and Mr Daniel Pruce (4th from left), Deputy Head of Mission, The British Embassy presided over the presentation of medicines to the Army Disaster Relief Center,...